J. Macdonald

C. Fenoglio-Preiser, G. Stemmermann, A. Noffsinger, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.

J. Crowley, C. Coltman, S. Martino, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adopting postoperative chemoradiotherapy in resected gastric cancer.

J. Macdonald, 2009, Gastrointestinal cancer research : GCR.

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

R. Labianca, D. Sargent, R. Goldberg, 2001, The New England journal of medicine.

Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

P. Catalano, A. Benson, C. Fuchs, 2002, Journal of the National Cancer Institute.

Gastric cancer: Chemotherapy of advanced disease

J. Macdonald, 1992, Hematological oncology.

Update on Adjuvant Therapy of Colon Cancer

D. Haller, J. Macdonald, 1997, Tumori.

Association of Hospital Procedure Volume and Outcomes in Patients with Colon Cancer at High Risk for Recurrence

J. Meyerhardt, P. Catalano, A. Benson, 2003, Annals of Internal Medicine.

Adjuvant treatment of gastric cancer

J. Macdonald, S. Schnall, 1995, World Journal of Surgery.

Some considerations concerning the dose and schedule of 5FU and leucovorin: toxicities of two dose schedules from the intergroup colon adjuvant trial (INT-0089).

D. Haller, J. Macdonald, M. Lefkopoulou, 1993, Advances in experimental medicine and biology.

Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential.

A. Goldin, J. Macdonald, E. Mihich, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Book reviewsRoentgenology of Lymphomas and Leukemias. By FelsonBenjamin, pp. x+134, 1980 (Grune and Stratton, New York), $24.50. ISBN 0–8089–1333–6

J. Macdonald, 1981 .

Endocrine tumors.

J. Macdonald, 1987, Seminars in oncology.

Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study.

A. Einstein, T. Fleming, C. Tangen, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New horizons for gastric cancer: commentary

A. Cervantes, J. Macdonald, 2006 .

Spontaneous streptococcus pneumonia peritonitis in a patient with metastatic gastric cancer. A case report and etiologic consideration

J. Isner, P. Schein, J. Macdonald, 1977, Cancer.

Nutritional complications of cancer and its treatment.

P. Schein, J. Macdonald, C. Waters, 1975, Seminars in oncology.

Osteoblastic bone metastasis in Zollinger-Ellison syndrome.

P. Schein, J. Macdonald, D. Haidak, 1976, Radiology.

Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm

P. Woolley, P. Schein, M. Lippman, 2004, Cancer Chemotherapy and Pharmacology.

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

Daniel F Hayes, R. Bast, M. Somerfield, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chapter 11 – SUBACUTE AND CHRONIC TOXICITIES ASSOCIATED WITH NITROSOUREA THERAPY

R. Weiss, J. Macdonald, D. Poster, 1981 .

In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.

C. Jasmin, G. Mathé, J. Macdonald, 1980, Cancer research.

Phase II trial of streptozotocin, mitomycin‐C and 5‐fluorouracil (SMF) in the treatment of advanced pancreatic cancer

P. Woolley, P. Schein, J. Macdonald, 1978, Cancer.

Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer

K. Chansky, J. Abbruzzese, G. Budd, 2002, Investigational New Drugs.

Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.

R. Glazer, P. Schein, J. Macdonald, 1980, Cancer research.

Current Results and Therapeutic Issues

J. Macdonald, 1989 .

Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer.

P. Woolley, P. Schein, J. Macdonald, 1978, Blood.

Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial.

S. Cha, D. Sargent, M. O’connell, 2002, International journal of radiation oncology, biology, physics.

Does Leucovorin Alter the Intratumoral Pharmacokinetics of 5-Fluorouracil (5-FU)? A Southwest Oncology Group Study

C. Presant, J. Jacobson, W. Wolf, 2002, Investigational New Drugs.

PROGNOSTIC FACTORS IN ADVANCED NON-SEMINOMATOUS GERM-CELL TESTICULAR TUMOURS: RESULTS OF A MULTICENTRE STUDY Report from the Medical Research Council Working Party on Testicular Tumours

K. Sikora, A. Horwich, P. Wilkinson, 1985, The Lancet.

Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.

S. Marsoni, J. Macdonald, D. Poster, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Effect of sulfhydryl-containing compounds on the antitumor effects of adriamycin.

R. W. Freeman, R. Olson, J. Oates, 1980, Toxicology and applied pharmacology.

Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.

C. Wiseman, J. Macdonald, R. Taylor, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of non-small cell lung cancer with coumarin and cimetidine.

J. Macdonald, K. Butler, L. Mendelsohn, 1987, Cancer treatment reports.

Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma.

J. Macdonald, J. Penta, D. Poster, 1982, American journal of clinical oncology.

Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma.

R. Glazer, T. Kensler, J. Macdonald, 1981, Biochemical pharmacology.

Chemoradiation of resected gastric cancer: A 10-year follow-up of the phase III trial INT0116 (SWOG 9008).

J. Ajani, D. Haller, J. Jessup, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study.

J. Abbruzzese, M. Rothenberg, T. Seay, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A southwest oncology group study

T. Fleming, R. Bukowski, L. Baker, 1993, Cancer.

High-dose cisplatin in disseminated melanoma: a comparison of two schedules

K. Kopecky, J. Mortimer, J. Macdonald, 2004, Cancer Chemotherapy and Pharmacology.

42 : A Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre and Post Chemoradiation (CRT) 5-FU vs. Gemcitabine (G) for Resected Pancreatic Adenocarcinoma

R. Abrams, C. Willet, A. Benson, 2006 .

Treatment of localized gastric cancer.

J. Macdonald, 2004, Seminars in oncology.

Recent results of clinical therapeutic trials for gastrointestinal malignancies conducted in the United States.

P. Schein, J. Macdonald, D. Kisner, 1981, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study

J. Crowley, R. Livingston, F. Muggia, 2004, Cancer Chemotherapy and Pharmacology.

A randomized trial of two schedules of trimetrexate versus 5‐fluorouracil in advanced colorectal cancer: a Southwest Oncology Group Study

T. Fleming, P. Goodman, J. Macdonald, 1995, Anti-cancer drugs.

SAMIT: Preliminary safety data from a 2x2 factorial randomized phase III trial to investigate weekly paclitaxel (PTX) followed by oral fluoropyrimidines (FPs) versus FPs alone as adjuvant chemotherapy in patients (pts) with gastric cancer.

M. Buyse, J. Sakamoto, S. Morita, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5‐fluorouracil, adriamycin, and mitomycin‐c (fam) combination chemotherapy in the treatment of advanced gastric cancer

P. Woolley, P. Schein, D. Hoth, 1979, Cancer.

Chemotherapy of gastric cancer.

J. Macdonald, J. J. Gohmann, 1989, Cancer investigation.

The Impact of Chemotherapy on the Treatment of Gastric Cancer

J. Macdonald, D. Kisner, 1983 .

Prediction of clinical response to 5-fluorouracil-containing chemotherapy: preliminary results of in vitro assay in human breast cancer.

P. Schein, M. Lippman, J. Macdonald, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Hexamethylmelamine: activity in lymphoma and other tumors.

J. Macdonald, 1991, Cancer treatment reviews.

Chemotherapy of advanced gastric cancer: present status, future prospects.

J. Macdonald, J. J. Gohmann, 1988, Seminars in oncology.

High incidence of coagulopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers

T. Fleming, P. Goodman, E. Hersh, 1992 .

High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers.

T. Fleming, P. Goodman, E. Hersh, 1992, Anti-cancer drugs.

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

G. Lyman, H. Lazarus, J. Ruckdeschel, 1991, Cancer.

Adjuvant therapy for gastric cancer.

J. Macdonald, 2003, Seminars in oncology.

Advances in the therapy of gastric cancer

J. Macdonald, 2002, Gastric Cancer.

Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy

P. Woolley, P. Schein, J. Macdonald, 1988, Investigational New Drugs.

Association of breast cancer with meningioma. Report of two cases and review of the literature

M. Slavik, J. Macdonald, F. Smith, 1978, Cancer.

Cutaneous seeding of pancreatic cancer by skinny-needle aspiration biopsy.

P. Schein, J. Macdonald, R. Ornitz, 1980, Archives of internal medicine.

Phase-II trial of tamoxifen in advanced breast cancer

P. Woolley, P. Schein, D. Hoth, 2004, Cancer Chemotherapy and Pharmacology.

Phase-II trial of tamoxifen in advanced breat cancer.

P. Woolley, P. Schein, D. Hoth, 1979, Cancer chemotherapy and pharmacology.

A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.

Y. Kodera, J. Sakamoto, S. Morita, 2005, Japanese journal of clinical oncology.

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

S. Balcerzak, J. Abbruzzese, J. Macdonald, 2004, Investigational new drugs.

Chemotherapy of large intestinal carcinoma. Current results and future prospects

P. Schein, J. Macdonald, D. Kisner, 1975, Cancer.

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

J. Cooper, M. Graham, S. Spencer, 1999, JAMA.

Therapies for Advanced Colorectal Cancer: The Role of Interferon and Leucovorin

J. Macdonald, 1997, Tumori.

Cutaneous T‐cell lymphoma

P. Schein, J. Macdonald, R. Edelson, 1976, Cancer.

Hepatic chemoembolization combined with systemic infusion of 5‐fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma

J. Doroshow, M. Zalupski, C. Leichman, 1999, Cancer.

Observations on the growth of tumours in lymph nodes changing from normal to abnormal while remaining opacified after lymphography.

M. Schlienger, J. Macdonald, A. Laugier, 1968, Clinical radiology.

Current diagnosis and management of pancreatic carcinoma.

P. Schein, J. Macdonald, L. Widerlite, 1976, Journal of the National Cancer Institute.

Δ9-Tetrahydrocannabinol in Clinical Oncology

J. Macdonald, J. Penta, D. Poster, 1981 .

delta 9-tetrahydrocannabinol in clinical oncology.

J. Macdonald, J. Penta, D. Poster, 1981, JAMA.

Hepatoma/merbarone

C. Tangen, J. Macdonald, E. Poplin, 2004, Investigational New Drugs.

Mitomycin C: Experience in the United States, with emphasis on gastric cancer

P. Schein, J. Macdonald, D. Hoth, 2004, Cancer Chemotherapy and Pharmacology.

Adjuvant chemotherapy in colon and gastric cancer.

D. Haller, J. Macdonald, D. Kisner, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Clinical strategies in the chemotherapy of gastrointestinal cancer.

P. Woolley, P. Schein, J. Macdonald, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A phase II trial of ftorafur. Adriamycin and mitomycin‐C (FAM II) in advanced gastric adenocarcinoma

P. Woolley, D. Haller, P. Schein, 1979, Cancer.

Mitomycin C: experience in the United States, with emphasis on gastric cancer.

P. Schein, D. Hoth, J. Macdonald, 1978, Cancer chemotherapy and pharmacology.

The detection and localisation of abdominal lymph node metastases from testicular teratomas.

T. Mcelwain, W. Hendry, J. Macdonald, 1977, British journal of urology.

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

P. Bunn, D. Ahnen, C. Fenoglio-Preiser, 1998, Cancer research.

Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.

J. Crowley, M. Leblanc, I. Thompson, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of lymphography in carcinoma of the prostate.

J. Macdonald, R. Paxton, G. Williams, 1975, British medical journal.

The role of computed tomography in the staging of bladder cancer.

J. Husband, J. Macdonald, N. Hodson, 1979, Clinical radiology.

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

J. Abbruzzese, J. Macdonald, J. Wade, 2005, Investigational New Drugs.

Delivering Effective & Meaningful Survivorship Care

J. Macdonald, Anita Chatigny, 2010 .

Lymphography in alveolar soft part sarcoma.

C. Parsons, J. Macdonald, 1977, Clinical radiology.

Computed Tomography in Testicular Disease: A Review

J E Husband, J. Husband, J. Macdonald, 1981, Journal of the Royal Society of Medicine.

Gastrointestinal involvement in the Sézary syndrome.

P. Schein, M. Cohen, A. Fischmann, 1977, Gastroenterology.

Impact of diabetes mellitus on outcomes in patients with colon cancer.

J. Meyerhardt, P. Catalano, A. Benson, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Book reviewsSoft Tissue Roentgenography in Diagnosis of Thyroid Cancer. By AkisadaMasayoshi and FujimotoYoshihide, pp. 138 (47 figs., 166 illus.), 1973 (Tokyo, Igaku Shoin Ltd.), ¥3,400.

J. Macdonald, 1974 .

The role of abdominal computed tomography in the management of testicular tumours.

J. Husband, J. Macdonald, M. Peckham, 1980, Computerized tomography.

Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.

V. Devita, A. Goldin, J. Venditti, 1981, European journal of cancer.

The value of lymphography in the management of bladder cancer.

J. Macdonald, D. Wallace, A. G. Turner, 1976, British journal of urology.

The accuracy of lymphography in Hodgkin's disease.

J. Gazet, J. Glees, J. Macdonald, 1974, Clinical radiology.

A review of the role of lymphography in the management of testicular tumours.

J. Macdonald, D. Wilkinson, 1975, Clinical radiology.

LYMPHANGIOGRAPHY IN TUMOURS OF THE KIDNEY, BLADDER AND TESTICLE.

J. Macdonald, E. Wallace, 1965, The British journal of radiology.

Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man.

J. Macdonald, D. Cooney, B. Ardalan, 1980, Advances in pharmacology and chemotherapy.

Phase I clinical trial of spirogermanium.

P. Woolley, P. Schein, M. Slavik, 1980, Cancer treatment reports.

The relation of p53 gene mutations to gastric cancer subsite and phenotype

C. Fenoglio-Preiser, G. Stemmermann, A. Noffsinger, 1999, Cancer Causes & Control.

A Southwest Oncology Group study

C. Tangen, G. Weiss, J. Macdonald, 1993 .

The potential for clinical application of in vitro assays predicting 5-FU sensitivity in man.

P. Schein, M. Lippman, J. Macdonald, 1981, Cancer treatment reports.

"High-dose" thymidine in clinical oncology.

J. Macdonald, D. Poster, S. Bruno, 1981, Cancer treatment reports.

Continuous low-dose infusion of fluorouracil: is the benefit worth the cost?

J. Macdonald, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Book review“Traité de Radiodiagnostic. Tome IV” Appareil Pulmonaire et Mediastin: Volume I. Edited BismuthV., pp. 528, illus., 1977 (Masson, Paris). $171.60, 660FF.

J. Macdonald, 1977 .

Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.

Daniel J Sargent, Daniel G Haller, Joel E Tepper, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.

D. Sargent, J. Ajani, J. Tepper, 2002, International Journal of Radiation Oncology, Biology, Physics.

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

J. Ajani, D. Haller, C. Blanke, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.

J. Tepper, A. Benson, M. O’connell, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.

H. Wieand, J. Krook, M. O’connell, 1994, The New England journal of medicine.

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Joon-Oh Park, Keunchil Park, Jeeyun Lee, 2005, International journal of radiation oncology, biology, physics.

Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of number of nodes retrieved on outcome in patients with rectal cancer.

C. Compton, J. Tepper, A. Benson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study.

T. Fleming, C. Tangen, C. Fabian, 1995, International journal of radiation oncology, biology, physics.

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

J. Tepper, A. Benson, M. O’connell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group study

T. Fleming, C. Tangen, A. Cruz, 1995, Annals of Surgical Oncology.

Etoposide in gastric cancer.

J. Macdonald, K. Havlin, 1992, Seminars in oncology.

Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid

T. Fleming, C. Tangen, H. Eyre, 1994, Cancer.

Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.

T. Fleming, C. Tangen, H. Eyre, 1994, Cancer.

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

P. Catalano, A. Hanlon, D. Haller, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.

P. Philip, A. Jazieh, J. Macdonald, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.

T. Fleming, J. Laurie, D. Haller, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial

R. Abrams, C. Willett, A. Benson, 2011, Annals of Surgical Oncology.

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

R. Abrams, C. Willett, A. Benson, 2008, JAMA.

A multicenter, Phase II trial of weekly irinotecan (CPT‐11) in patients with previously treated colorectal carcinoma

J. Hainsworth, C. Geyer, D. V. Von Hoff, 1999, Cancer.

Methyl mercury-induced encephalopathy in mice.

R. Harbison, J. Macdonald, 1977, Toxicology and applied pharmacology.

Biology, diagnosis, and chemotherapeutic management of pancreatic malignancy.

P. Schein, J. Macdonald, L. Widerlite, 1977, Advances in pharmacology and chemotherapy.

CANCER CHEMOTHERAPY AND THE LIVER

J. Macdonald, 1998 .

Abstracts reprinted from Journal of Clinical Oncology

S. Lipsitz, A. Benson, E. Guadagnoli, 2002, Annals of Surgical Oncology.

Autoimmune neutropenia following peripheral blood stem cell transplantation

J. Herman, J. Macdonald, T. Klumpp, 1992, American journal of hematology.

Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach

Zhong Zheng, Yun Yen, Chandan Guha, 2016, Pancreas.

Lymphatic diverticulum: a persistent posterior lymph sac demonstrated by lymphography.

J. Macdonald, L. Nuttall, 1977, Radiology.

Bone changes in adult acute leukaemia.

V. R. McCready, J. Macdonald, H. Ngan, 1968, The British journal of radiology.

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Computed tomography applied to radiotherapy treatment planning: techniques and results.

R. P. Parker, J. Husband, R P Parker, 1979, Radiology.

Selective transseptal angiocardiography of the left side of the heart.

J. Macdonald, B. Miller, B. L. Miller, 1962, Clinical radiology.

Book reviewsAtlas of Axial Transverse Tomography and Its Clinical Application. By TakahashiShinji, 1969 (Berlin, Heidelberg and New York, Springer-Verlag), DM.144.

J. Macdonald, 1970 .

Alterations in exon 4 of the p53 gene in gastric carcinoma.

C. Fenoglio-Preiser, G. Stemmermann, A. Noffsinger, 2000, Gastroenterology.

An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.

T R Fleming, T. Fleming, C. Tangen, 1993, JAMA.

Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma

J. Meyerhardt, P. Catalano, A. Benson, 2003, Cancer.

S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5-Fluorouracil, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach

B. Issell, K. Chansky, C. Blanke, 2009, American journal of clinical oncology.

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.

H. Gundacker, H. Lenz, M. Press, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Assessment of HER 2 gene ampli fi cation in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116 / SWOG 9008 clinical trial

H. Gundacker, H. Lenz, M. Press, 2013 .

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

H. Wieand, M. O’connell, D. Haller, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of amonafide in advanced pancreas cancer

T. Fleming, C. Tangen, J. Macdonald, 1993, Investigational New Drugs.

Amonafide treatment of refractory esophageal cancer

R. Fisher, J. Macdonald, E. Poplin, 1993, Investigational New Drugs.

A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a Southwest Oncology Group study.

T. Fleming, P. Goodman, E. Hersh, 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

T. Fleming, P. Goodman, E. Hersh, 1990, Journal of biological response modifiers.

Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

P. Catalano, A. Hanlon, D. Haller, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.

A. Benson, C. Willett, T. Showalter, 2011, International journal of radiation oncology, biology, physics.

Number of Lymph Nodes Analyzed : A Secondary Survey of Intergroup Tria l INT-0089

P. Catalano, A. Hanlon, D. Haller, 2003 .

The value of lymphography in the management of carcinoma of the cervix.

C. Perry, J. Macdonald, E. Smales, 1986, Clinical radiology.

Management of Gastric and Pancreatic Cancer

M. Citron, J. Macdonald, F. Smith, 1980 .

Chemotherapy of metastatic gastrointestinal cancers: prospects for future adjuvant systemic therapies.

J. Macdonald, D. Kisner, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Unusual Cancers of the Pancreas

J. Berlin, C. Shi, J. Macdonald, 2012 .

Clinical Trials with Antiemetic Agents in Cancer Patients Receiving Chemotherapy

J. Macdonald, J. Penta, D. Poster, 1981, Journal of clinical pharmacology.

A Phase II Trial of Topotecan in Esophageal Carcinoma: A Southwest Oncology Group Study (SWOG 9339)

G. Weiss, J. Jacobson, J. Kuebler, 2000, Investigational New Drugs.

Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study

S. Balcerzak, J. Macdonald, J. Benedetti, 2004, Investigational New Drugs.

Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)

D. Alberts, J. Macdonald, J. Benedetti, 2004, Investigational New Drugs.

Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study

K. Chansky, J. Abbruzzese, P. Vanveldhuizen, 2004, Investigational New Drugs.

Toxicity of 5-fluorouracil.

J. Macdonald, 1999, Oncology.

A phase II trial of continuous infusion vinblastine in patients with gastric carcinoma. A Southwest Oncology Group study.

P. Goodman, C. Presant, D. V. Von Hoff, 1990, European journal of cancer.

5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.

P. Woolley, P. Schein, J. Macdonald, 1976, Cancer treatment reports.

Differences in toxicity between men and women treated with 5‐fluorouracil therapy for colorectal carcinoma

K. Chansky, J. Macdonald, J. Benedetti, 2005, Cancer.

Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors.

P. Schein, J. Macdonald, D. Cooney, 1979, Bulletin du cancer.

Clinical overview: adjuvant therapy of gastrointestinal cancer

J. Macdonald, 2004, Cancer Chemotherapy and Pharmacology.

Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment

S. Hundahl, J. Macdonald, J. Benedetti, 2002, Annals of Surgical Oncology.

Synthesis and pharmacological study of a polymer which selectively binds mercury.

T. Pratt, R. Harbison, M. Jones, 1977, Toxicology and applied pharmacology.

Carcinoembryonic antigen screening: pros and cons.

J. Macdonald, 1999, Seminars in oncology.

Lymphography in carcinoma of the uterus.

J. Macdonald, J. W. Baker, B. Douglas, 1972, Clinical radiology.

The CT appearances of hepatic oil embolism following lymphography.

J. Macdonald, E. Silverstone, R. Blaquiere, 1984, The British journal of radiology.

Tumorigenicity of 7,12-dimethylbenz[a]anthracene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse.

A. Y. Lu, M. Juliana, J. Macdonald, 1981, Carcinogenesis.

Palliative chemotherapy and hormonal therapy.

M. Metcalfe, E. Romond, J. Macdonald, 1985, Seminars in oncology.

Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study

P. Goodman, T. Fleming, J. Macdonald, 1993, Anti-cancer drugs.

A phase II trial of piroxantrone in adenocarcinoma of the pancreas

C. Tangen, G. Weiss, J. Macdonald, 1993, Investigational new drugs.

RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma.

R. Abrams, C. Willett, A. Benson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

Christopher G Willett, R. Abrams, C. Willett, 2012, International journal of radiation oncology, biology, physics.

PHASE III TRIAL OFADJUVANT CHEMOTHERAPYAND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS

R. Abrams, C. Willett, A. Benson, 2011 .

ALL SOUTHWEST ONCOLOGY GROUP MEMBER, CCOP AND AFFILIATE MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, SURGEONS AND PATHOLOGISTS; ECOG AND RTOG

J. Macdonald, C. White, L. Kaye, 2002 .

Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.

G. Weiss, R. Goldberg, D. Haller, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract.

J. Macdonald, R. Mahtani, 2008, The oncologist.

5‐fluorouracil, adriamycin, and mitomycin‐C (FAM) chemotherapy for adenocarcinoma of the lung

P. Woolley, P. Schein, J. Macdonald, 1979, Cancer.

39 : RTOG 9704 - Radiotherapy Quality Assurance (QA) Review and Survival

R. Abrams, C. Willett, A. Benson, 2006 .

Impact o f D iabetes M ellitus o n O utcomes i n P atients W ith Colon C ancer

J. Meyerhardt, P. Catalano, A. Benson, 2003 .

CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.

P. Woolley, P. Schein, D. Hoth, 1981, Cancer treatment reports.

Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin

J. Montero, G. Mathé, J. Imbach, 1979, Cancer Chemotherapy and Pharmacology.

Phase II trial to topotecan in hepatocellular carcinoma: A Southwest Oncology Group study

M. O'Rourke, R. Natale, J. Macdonald, 2004, Investigational New Drugs.

Adjuvant therapy of colon cancer

J. Macdonald, J S Macdonald, 1999, CA: a cancer journal for clinicians.

Adjuvant therapy for colon cancer

J. Macdonald, 1997 .

Therapy of Advanced Gastric Carcinoma: The Georgetown‐Lombardi Cancer Center Experience

P. Woolley, P. Schein, J. Macdonald, 1989, American Journal of Clinical Oncology.

Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.

P. Schein, J. Misset, C. Jasmin, 1982, European journal of cancer & clinical oncology.

Bis-diketopiperazine derivatives in clinical oncology: ICRF-159.

S. Marsoni, J. Macdonald, J. Penta, 1980, Cancer clinical trials.

Impact of Hospital Volume on Recurrence and Survival After Surgery for Gastric Cancer

J. Meyerhardt, C. Fuchs, P. Enzinger, 2007, Annals of surgery.

Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-Fluorouracil in advanced gastric adenocarcinoma

T. Fleming, J. Macdonald, S. Richman, 1996, Investigational New Drugs.

Changes in the size of pelvic lymph nodes in patients being followed after radiotherapy for Hodgkin's disease.

M. Williams, J. Macdonald, M. Peckham, 1980, Clinical radiology.

Mitomycin therapy in gastric cancer.

J. Macdonald, S. Schnall, 1993, Oncology.

Phase II study of 5‐fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study

T. Fleming, C. Tangen, L. Hutchins, 1995, Cancer.

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

H. Lenz, S. Dakhil, J. Abbruzzese, 2006, Investigational New Drugs.

Chemotherapy of adenocarcinoma of the pancreas.

J. Macdonald, S. Schnall, 1996, Seminars in Oncology.

COMPUTERISED AXIAL TOMOGRAPHY FOR DIAGNOSIS OF PANCREATIC CANCER

D. Schellinger, P. Schein, J. Harbert, 1976, The Lancet.

Phase II trial of trimetrexate in advanced esophageal cancer: A southwest oncology group study

T. Fleming, J. Macdonald, T. Brown, 1995, Investigational New Drugs.

A randomized trial of surgery in the treatment of single metastases to the brain.

Y Maruyama, W R Markesbery, J W Walsh, 1990, The New England journal of medicine.

Phase II Trial of Merbarone in Pancreatic Carcinoma: A Southwest Oncology Group Study

E. Kraut, L. Baker, T. Fleming, 1993, American journal of clinical oncology.

Improved therapeutic ratio with protracted venous infusion (PVI) 5-fluorouracil (5FU) during postoperative external beam radiotherapy for high-risk rectal cancer

H. Wieand, J. Krook, M. O’connell, 1993 .

Lymphography in the management of urinary tract tumours.

J. Macdonald, B. Higgs, 1968, British journal of urology.

The value of lymphography to the radiotherapist.

J. Macdonald, 1969, Clinical radiology.

Treatment of non-small cell lung cancer with coumarin and cimetidine.

J. Macdonald, K. Butler, L. Mendelsohn, 1987, Cancer treatment reports.

Inadequate documentation and resection for gastric cancer in the United States: a preliminary report.

K. Touijer, N. Estes, J. Macdonald, 1998, The American surgeon.

Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant.

E. Romond, J. Macdonald, P. Henslee-Downey, 1996, Transplantation.

Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study

K. Sikora, A. Horwich, P. Wilkinson, 1985 .

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial.

G. Ferretti, J. Macdonald, T. Lillich, 1990, Oral surgery, oral medicine, and oral pathology.

Pharmacokinetics of ondansetron in patients receiving cisplatin therapy.

M. Chandler, J. Macdonald, M. Parr, 1992, Clinical pharmacy.

VM-26 in gastric cancer

B. Barlogie, C. Tangen, J. Berenberg, 1993, Investigational New Drugs.

Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.

P. Woolley, D. Haller, P. Schein, 1978, Cancer treatment reports.

Mitomycin C: Experience in the United States, with emphasis on gastric cancer

P. Schein, J. Macdonald, D. Hoth, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Mitomycin C: experience in the United States, with emphasis on gastric cancer.

P. Woolley, P. Schein, J. Macdonald, 1978, Cancer chemotherapy and pharmacology.

The lymphographic pattern in Hodgkin's disease: a correlation with the Rye histological classification.

D. Stoker, I. Gordon, J. Macdonald, 1976, Clinical radiology.

Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study.

G. Weiss, J. Jacobson, J. Macdonald, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group.

T. Fleming, C. Tangen, J. Laurie, 1998, Annals of internal medicine.

Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01)

J. Cooper, M. Graham, S. Spencer, 1999 .

FIBROMUSCULAR HYPERPLASIA OF THE RENAL ARTERIES.

J. Macdonald, J. Mcmillan, 1963, Clinical radiology.

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.

H. Gundacker, H. Lenz, M. Press, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Book reviewsLa Lymphographie Normale et Pathologique. By GrelletJ., MarkovitsP., HeitzF. and GasquetC., pp. 119 (Neuchatel and Paris, Delachaux & Niestlé).

J. Macdonald, 1970 .